Navigation Links
Lilly Receives NCQA Health Information Product Certification for Interactive Online Health Education Answers Program
Date:11/24/2008

INDIANAPOLIS, Nov. 24 /PRNewswire-FirstCall/ -- Lilly's (NYSE: LLY) Health Education Answers, an interactive online program, has received Health Information Product Certification from the National Committee for Quality Assurance (NCQA) for the Health Risk Appraisals and Interactive Consumer Health Tools certification options. NCQA is a private, non-profit organization dedicated to providing health care quality information through the Web and the media in order to help consumers, employers, and others make more informed health care choices.

"Earning NCQA's Health Information Product Certification demonstrates that an organization has expertise in gathering and disseminating health care information for patients," said Kathleen C. Mudd, vice president, Product Delivery, NCQA. "Lilly is to be commended for being the first pharmaceutical company in the nation to be reviewed for these services."

Health Education Answers is a Web-based program designed for managed care and public payer organizations to assist in further driving the standard of patient care through interactive educational information. Patients accessing the program can progress through an entire neighborhood of health education and disease management modules, including: ADHD, Bipolar Disorder, Depression, Diabetes, Diabetes Complications, Manage Your Weight, Medication Safety, Men's Health, Schizophrenia, Smoking & Addictions, and Women's Health.

Available in English and Spanish with full audio, the Health Education Answers program includes research-supported patient education material that adheres to national clinical guidelines. This tool educates patients on several health areas, including proper diet and exercise, healthy habits to teach their kids, and simple steps to help themselves and their families prevent illness.

Health Education Answers also includes an optional health risk assessment that helps patients identify and understand their individual health needs and at-risk behaviors and suggestions for improvement. Based on the results, Health Education Answers then directs patients to the most applicable education modules.

"The Health Education Answers program is another example of Lilly's commitment to going beyond medicine to support the overall health needs of patients," said Jack Bailey, vice president, Lilly. "Receiving HIP certification is especially important to us because it is an external validation from an independent team of health care professionals that this intervention meets rigorous quality standards."

Programs such as Health Education Answers improve health and wellness while reducing health care costs for payers and their patients. According to a report released by the Trust for America's Health, researchers indicate that preventive measures will reduce the cost of health care, estimating that for an annual investment of $10 in a "proven" community prevention program, the return on investment in 10 to 20 years will exceed $6 for every dollar invested.(i)

Lilly also offers three Disease Management programs with NCQA Program Design Certification as part of its ongoing commitment to improving the standard of patient care. They include:

-- Tools That Empower(TM) Depression Care Management Program -- A program designed for managed care organizations to assist in further driving the standard of patient care around Major Depressive Disorder.

-- Tools That Empower(TM) Diabetes Management Program -- A robust diabetes disease management program that contains more than 20 best-in-class tools and resources for care managers and diabetes program directors.

-- HealthInsights for Women -- A disease management program designed for women aged 30 years and older that provides information about disease risk factors and encourages them to make behavior changes that can lead to better health.

For more information about Lilly's disease management and health education programs, visit Lilly.com and LillyforBetterHealth.com

About NCQA:

NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA is committed to providing health care quality information through the Web and the media in order to help consumers, employers and others make more informed health care choices.

Consumers can access an organization's NCQA Accreditation and Certification status and other information on health care quality on NCQA's Web site at www.ncqa.org, or by calling NCQA Customer Support at (888) 275-7585.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

O-LLY

(i) Trust for America's Health, Blueprint for a Healthier America: Modernizing The Federal Public Health System To Focus On Prevention And Preparedness, Washington, DC: Trust for America's Health, October 2008. http://healthyamericans.org/assets/files/Blueprint.pdf (accessed Nov. 4, 2008).

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: